Janux Therapeutics, Inc. (JANX) Institutional Ownership

Institutions by Trading Activity

61,014,970Shares Outstanding

88Shares held by institutions

$1,246Value of institutional holdings

0.22%Institutional ownership %

61.71%Shares Changed QoQ

4No. of institutional investors

The institutional landscape for Janux Therapeutics, Inc. (NASDAQ:JANX) includes 4 filers as of the latest reporting cycle ending December 2025.

The percentage of Janux Therapeutics owned by institutions changed from 106.8% in September 2025 to 0.2% in December 2025, marking a slight down trend.
The company experienced a 61.71% quarterly change in institutional shares held, alongside a decrease of 98.14% in total owners annually.
A review of institutional activity for Janux Therapeutics shows 3 of 4 filers increasing their positions, while 0 reduced their stake, and 1 remained unchanged.
Collectively, institutional investors increased their stake in Janux Therapeutics to 137.26K shares as of December 2025, a change that is up by 52.38K shares quarter on quarter and down 63.98Mn shares year over year.
With 79.82K shares, SG Americas Securities, LLC commands the largest institutional position in Janux Therapeutics as of December 31, 2025, equating to 0.13% of the company.
Among the most significant buyers of Janux Therapeutics during December 2025 were SG Americas Securities, LLC (50.80K), CONGRESS ASSET MANAGEMENT CO (1.57K), GAMMA Investing LLC (8).
The top 4 institutional holders of Janux Therapeutics for the quarter ending December 2025 included SG Americas Securities, LLC (79.82K), CONGRESS ASSET MANAGEMENT CO (57.34K), Aventura Private Wealth, LLC (88), GAMMA Investing LLC (16).

88 Total Shares Held

Rows:

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
RA CAPITAL MANAGEMENT, L.P.	30 Sep, 2025	11,189,693	0	0.00%	$273,476,097.00
FMR LLC	30 Sep, 2025	9,056,062	167,320	1.88%	$221,330,155.00
JANUS HENDERSON GROUP PLC	30 Sep, 2025	4,701,112	240,780	5.40%	$114,988,241.00
BlackRock, Inc.	30 Sep, 2025	3,730,994	328,147	9.64%	$91,185,492.00
Paradigm Biocapital Advisors LP	30 Sep, 2025	2,920,258	0	0.00%	$71,371,106.00
ADAGE CAPITAL PARTNERS GP, L.L.C.	30 Sep, 2025	2,775,000	250,000	9.90%	$67,821,000.00
VANGUARD GROUP INC	30 Sep, 2025	2,417,104	227,676	10.40%	$59,074,022.00
STATE STREET CORP	30 Sep, 2025	1,891,465	503,357	36.26%	$46,227,405.00
ORBIMED ADVISORS LLC	30 Sep, 2025	1,766,100	555,800	45.92%	$43,163,484.00
Point72 Asset Management, L.P.	30 Sep, 2025	1,710,200	-433,700	-20.23%	$41,797,288.00
PRICE T ROWE ASSOCIATES INC /MD/	30 Sep, 2025	1,265,556	-527,871	-29.43%	$30,931.00
GEODE CAPITAL MANAGEMENT, LLC	30 Sep, 2025	1,083,864	181,552	20.12%	$26,494,551.00
Woodline Partners LP	30 Sep, 2025	1,026,938	-215,000	-17.31%	$25,098,365.00
T. Rowe Price Investment Management, Inc.	30 Sep, 2025	972,691	972,691	0.00%	$23,773.00
READYSTATE ASSET MANAGEMENT LP	30 Sep, 2025	960,379	264,423	37.99%	$23,471,663.00
Logos Global Management LP	30 Sep, 2025	935,000	-65,000	-6.50%	$22,851,400.00
FRANKLIN RESOURCES INC	30 Sep, 2025	887,755	-181,440	-16.97%	$21,696,730.00
Prosight Management, LP	30 Sep, 2025	865,350	11,446	1.34%	$21,149,154.00
Cormorant Asset Management, LP	30 Sep, 2025	850,000	-650,000	-43.33%	$20,774,000.00
CITADEL ADVISORS LLC	30 Sep, 2025	802,784	802,784	0.00%	$19,620,041.00

1 - 20 of 173